Back
Celldex Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
CLDX
Sponsored
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Buy
57
CLDX
Celldex Therapeutics
Last Price:
41.23
Seasonality Move:
-1.09%
7 Day Trial
ALL ACCESS PASS
$
7
10 minutes on Tuesday - $1,270 by Friday?
Click here to discover how this "odd" trade could double your money each week.Celldex Therapeutics Price Quote
$41.23
-0.01 (0.17%)
(Updated: September 21, 2024 at 6:16 AM ET)
Celldex Therapeutics Key Stats
Buy
57
Celldex Therapeutics (CLDX)
is a Buy
Day range:
$40.45 - $41.88
52-week range:
$22.11 - $53.18
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
278.45
P/B ratio:
3.36%
Volume:
908.9K
Avg. volume:
697.5K
1-year change:
57.04%
Market cap:
$2.7B
Revenue:
$6.9M
EPS:
$-2.75
How Much Does Celldex Therapeutics Make?
-
How Much Are Celldex Therapeutics's Sales Annually?
CLDX Revenues are $6.9M -
How Much Profit Does Celldex Therapeutics's Make A Year?
CLDX net income is -$141.4M
Is Celldex Therapeutics Growing As A Company?
-
What Is Celldex Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 8.32% -
What Is Celldex Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Celldex Therapeutics Stock Price Performance
-
Did Celldex Therapeutics Stock Go Up Last Month?
Celldex Therapeutics share price went up by 15.32% last month -
Did CLDX's Share Price Rise Over The Last Year?
CLDX share price rose by 57.04% over the past 1 year
What Is Celldex Therapeutics 52-Week High & Low?
-
What Is Celldex Therapeutics’s 52-Week High Share Price?
Celldex Therapeutics has traded as high as $53.18 over the past 52 weeks -
What Is Celldex Therapeutics’s 52-Week Low Share Price?
Celldex Therapeutics has traded as low as $22.11 over the past 52 weeks
Celldex Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Celldex Therapeutics?
-
How Much Debt Does Celldex Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Celldex Therapeutics Have?
Cash and short term investments quarterly total is $802.3M -
What Is Celldex Therapeutics’s Book Value Per Share?
Book value per share is 12.28
Is Celldex Therapeutics Cash Flow Positive?
-
What Is CLDX Cash Flow From Operations?
Cash flow from operations (TTM) is -$121.5M -
What Is Celldex Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $657.5M -
What Is Celldex Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$521.4M
Celldex Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
CLDX return on invested capital is -28.83% -
What Is Celldex Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -27.22% -
What Is CLDX Return On Equity?
ROE is a measure of profitability and is -28.83%
Celldex Therapeutics Earnings Date & Stock Price
-
What Is Celldex Therapeutics's Stock Price Today?
A single share of CLDX can be purchased today for 41.24 -
What Is Celldex Therapeutics’s Stock Symbol?
Celldex Therapeutics trades on the nasdaq under the ticker symbol: CLDX -
When Is Celldex Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Celldex Therapeutics is scheduled on November 1, 2024 -
When Is CLDX's next ex-dividend date?
Celldex Therapeutics's next ex-dividend date is May 16, 2020 -
How To Buy Celldex Therapeutics Stock?
You can buy Celldex Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Celldex Therapeutics Competitors
-
Who Are Celldex Therapeutics's Competitors?
Below is a list of companies who compete with Celldex Therapeutics or are related in some way:
Celldex Therapeutics Dividend Yield
-
What Is CLDX Dividend Yield?
Celldex Therapeutics’s dividend yield currently is 0% -
What Is Celldex Therapeutics’s Payout Ratio?
Celldex Therapeutics’s payout ratio is 0% -
When Did Celldex Therapeutics Last Pay A Dividend?
The latest dividend pay date is September 21, 2024 -
What Is Celldex Therapeutics’s Dividend Per Share?
Celldex Therapeutics pays a dividend of $0.00 per share
Celldex Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 8.99% |
Revenue: | 832.09% | 192.41% |
Analyst Recommendations
Buy Recommendations: | 8 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 0 |
Price Target: | 67.00 |
Upside from Last Price: | 62.46% |